Las Vegas, NV -- (SBWIRE) -- 01/22/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Shanda Games Limited(ADR)(NASDAQ:GAME), Vector Group Ltd(NYSE:VGR), ARMOUR Residential REIT, Inc.(NYSE:ARR), Keryx Biopharmaceuticals(NASDAQ:KERX)
Shanda Games Limited(ADR)(NASDAQ:GAME) was a volume gainer of 4.72 million shares and the average volume of the stock remained 1.03 million shares. The stock opened the session at $4.70 and finished at the end of the day at $5.08 and the stock escalated 6.50%.The market capitalization of the stock remained 1.37 billion. Shanda Games Limited develops, sources, and operates online games in the People?s Republic of China. Shanda Games Limited was founded in 2001 and is headquartered in Shanghai, the People?s Republic of China.
For How Long GAME will fight for Profitability? Read This Trend Analysis report
In the preceding trading session, Vector Group Ltd(NYSE:VGR) exchanged 4.70 million shares and the average volume remained 472,822.00 shares. The stock closed the session at $17.79 with the gain of 7.10%. Vector Group Ltd., through its subsidiaries, engages in the manufacture and sale of cigarettes in the United States. The company operates in Tobacco and Real Estate segments. The company, formerly known as Brooke Group Ltd., was founded in 1911 and is based in Miami, Florida.
Will VGR Continue To Move Higher? Find Out Here
ARMOUR Residential REIT, Inc.(NYSE:ARR) enhanced 0.99% and its closing price was $4.08. The volume of the stock was 4.29 million shares and the average volume remained 6.21 million shares. The market capitalization of the stock remained 1.51 billion. The beta of the stock remained 0.67. ARMOUR Residential REIT, Inc. is a real estate investment trust launched and managed by ARMOUR Residential Management LLC. It invests in the real estate markets of the United States.
Why Should Investors Buy ARR After The Recent Gain? Just Go Here and Find Out
Keryx Biopharmaceuticals(NASDAQ:KERX) exchanged 4.38 million shares in the previous trading session, and its average trading remained 2.72 million shares. KERX advanced 1.05% and it closed the trading at $15.38. The market capitalization of the stock remained 1.27 billion. Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States.
For How Long KERX’s Gloss will Attract Investors? Find out via this report
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/">http://www.equityobserver.com/&l...; employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/>
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)